ON-DEMAND WEBINAR
Optimizing high-content screening tools for physiologically-relevant 3D in vitro models
Overcome challenges in high-throughput 3D imaging
Optimizing high-content screening tools for physiologically-relevant 3D in vitro models
Elodie Vandenhaute, Study Director | HCS Pharma
Zied Souguir, Senior Scientist | HCS Pharma
Dan O’Connor, North America Bioimaging Director | Molecular Devices
Watch our webinar with HCS Pharma, a biotechnology start-up company based in France, as we discuss the biological characterization of cells in 3D matrices for liver, brain and adipose tissues, and cancer modeling, using BIOMIMESYS® hydroscaffold technology. We also discuss high-content screening solutions for examining 3D in vitro models.
Key learning objectives:
- Describe the differentiating factors between different 3D cell culture systems
- Utilizing a relevant 3D cell culture platform for liver, brain, adipose tissue, and disease modeling (human cells)
- Optimizing setup of a high-content screening platform for 3D in vitro models